Balkan medical journal, vol.37, no.3, pp.138-143, 2020 (SCI-Expanded)
Background: Cell-free DNA, which may be considered as "liquid" biopsy, may serve as a diagnostic and prognostic marker not only in hematological malignancies but in solid tumors as well.